11/01/05 - OCI Fall Newsletter
11/01/05 - Study Suggests Common Cholesterol-Lowering Drugs Can Reduce Prostate Cancer Risk
10/25/05 - Dirty Drugs Have Their Day
10/05/05 - Gleevec Combination Prevents Resistance In Leukemia Cells
10/04/05 - The man behind the cure
09/28/05 - Thousands Fight Cancer With Lance Armstrong At The LIVESTRONG Ride
09/26/05 - Survivors, supporters cycle against cancer
09/05/05 - Oregon Man & Woman of the Year
08/23/05 - Cancer's Lost Generation
07/28/05 - National Cancer Institute Approves $10 Million Award for OHSU Cancer Institute
07/07/05 - OHSU Researchers Investigate Fatigue in Cancer Patients
06/08/05 - OHSU Performs Bone Marrow Transplant No. 1,000
05/16/05 - OHSU Cancer Research Presented at National Meeting
05/16/05 - Presence OF High-Risk Prostate Cancer Can Be Predicted Without A Biopsy, New Study Says
05/16/05 - Molecular Testing In Patients With Rare Cancer Predicts Response To Gleevec
05/16/05 - Vitamin D, Taxotere Combination Promising For Advanced Prostate Cancer
04/25/05 - OHSU Cancer Institute Leads First Study of New Targeted Drug As First-Line Kidney Cancer Treatment
04/25/05 - OHSU Cancer Institute to Help Lead International High-Tech Cancer Research Collaboration
04/15/05 - Distinguised New Specialists Enhance Urologic Cancer Treatment and Research at OHSU
03/29/05 - OHSU Scientists Test Medication Under Development For AIDS, Cancer Patients Suffering From Severe Involuntary Weight Loss
02/23/05 - OHSU Scientists Develop MRI Approach to Improve Breast Cancer Detection
02/22/05 - New Study on Gleevec Resistance Reinforces Principle of Targeted Therapy for Cancer Treatment
NO DATE - OHSU Cancer Institute Breast Health Education Program Unique in Broad-Based Teaching of New Recommendatons
NO DATE - Increasingly Used Prostate Cancer Treatment Less Effective for Younger Men with Higher Grade Tumors
NO DATE - OHSU Cancer Institute Researcher, Cancer Survivor to Ride with Lance Armstrong in Tour of Hope
